checkAd

     832  0 Kommentare The Medicines Company Adds Novel, Approved, Surgical Sealant to Its Surgical Hemostasis Portfolio - Seite 2

    "We are excited to be involved in a transaction with The Medicines Company, which will allow more patients to have access to this beneficial technology," Ronald Dieck, President and CEO of Tenaxis commented. "We are proud of the surgical sealant technologies that we have developed and their impact on the wellbeing of patients. The Medicines Company is clearly committed to the area of intraoperative hemostasis and we look forward to working as a team to innovate in this area of medicine."

    The Boards of Directors of both companies have unanimously approved the agreement.

    Anzeige 
    Handeln Sie Ihre Einschätzung zu Pfizer!
    Long
    26,21€
    Basispreis
    0,19
    Ask
    × 13,77
    Hebel
    Short
    30,23€
    Basispreis
    0,20
    Ask
    × 13,08
    Hebel
    Präsentiert von

    Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie bei Klick auf das Disclaimer Dokument. Beachten Sie auch die weiteren Hinweise zu dieser Werbung.

    Gibbons P.C. served as legal advisor for the transaction for The Medicines Company. Leerink Swann & Co. served as financial advisor and Wilson Sonsini Goodrich & Rosati, PC served as legal advisor for the transaction for Tenaxis Medical, Inc.

    Conference Call Information

    There will be a conference call with The Medicines Company management today at 8:30 a.m. Eastern Time to discuss the Tenaxis acquisition, first quarter 2014 financial results, operational developments, and outlook. The conference call will be available via phone and webcast. The webcast can be accessed at www.themedicinescompany.com.

    Domestic Dial In: +1 (877) 359-9508
    International Dial In: +1 (224) 357-2393
    Passcode for both dial in numbers: 27882505

    Replay is available from 11:30 a.m. Eastern Time following the conference call through May 7, 2014. To hear a replay of the call dial +1 855 859-2056 (domestic) and +1 404 537-3406 (international). Passcode for both dial in numbers is 27882505.

    About The Medicines Company

    The Medicines Company's purpose is to save lives, alleviate suffering and contribute to the economics of healthcare by focusing on 3000 leading acute/intensive care hospitals worldwide. Its vision is to be a leading provider of solutions in three areas: acute cardiovascular care, surgery and perioperative care, and serious infection disease care. The company operates in the Americas, Europe and the Middle East, and Asia Pacific regions with global centers today in Parsippany, NJ, USA and Zurich, Switzerland.

    About Tenaxis Medical, Inc.
    Located in Mountain View, CA, Tenaxis Medical, Inc. is a privately held company that began operations in 2006. It develops novel, high performance sealants that are designed to meet unmet needs throughout various medical procedures. The products are based on a patent foundation that allows for the development of sealants with wide mechanical and chemical properties.

    Seite 2 von 3




    Verfasst von Marketwired
    The Medicines Company Adds Novel, Approved, Surgical Sealant to Its Surgical Hemostasis Portfolio - Seite 2 PARSIPPANY, NJ and MOUNTAIN VIEW, CA--(Marketwired - Apr 23, 2014) - The Medicines Company (NASDAQ: MDCO) and Tenaxis Medical, Inc. (Tenaxis) today announced an agreement for The Medicines Company to acquire Tenaxis. Tenaxis's sole product, which …

    Schreibe Deinen Kommentar

    Disclaimer